Fibrate-associated adverse effects beyond muscle and liver toxicity.

Fibrate derivatives have a 40-year history in the management of dyslipidemia. Although this class of drugs is generally well tolerated, several safety issues have arisen from their use. In the present article we review the literature describing side effects associated with the use of fibrates except for those that are liver and muscle related. These effects are less well known but are clinically relevant.

作 者：

Florentin,M；Liberopoulos,EN；Mikhailidis,DP；Elisaf,MS

刊 名：

Current pharmaceutical design 

年，卷(期)：

2008vol.14(no.6) 

分类号：

 

关键词：

Animals  Clinical Trials as Topic  Clofibric Acid  Humans  Liver Diseases  动物  氯贝酸  肝疾病  肌, 骨骼  肌疾病

正文语种：

eng 

基金项目：